SciBase Holding AB (OSTO:SCIB) Construction In Progress: kr0.00 Mil (As of Mar. 2026)


OSTO:SCIB SciBase Holding AB OSTO:SCIB
50 GF Score
Price kr33.80
GF Value kr21.74
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is SciBase Holding AB Construction In Progress?

SciBase Holding AB OSTO:SCIB +0.30% 50 Construction In Progress is kr0.00 Mil as of Mar. 2026. GuruFocus rates OSTO:SCIB with a GF Score™ of 50/100 and a GF Value™ of kr21.74 (Significantly Overvalued). The stock has 4 warning signs investors should review.

SciBase Holding AB Construction In Progress Historical Data

* Premium members only.

The historical data trend for SciBase Holding AB's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SciBase Holding AB Construction In Progress Chart

SciBase Holding AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SciBase Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSTO:SCIB
50GF Score
SciBase Holding AB OSTO:SCIB
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SciBase Holding AB Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of kr0.00 Mil mean?
SciBase Holding AB (OSTO:SCIB) has a Construction In Progress of kr0.00 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on SciBase Holding AB and its competitors.
Is SciBase Holding AB's Construction In Progress too high?
SciBase Holding AB's current Construction In Progress is kr0.00 Mil. Overall, SciBase Holding AB has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SciBase Holding AB's Construction In Progress compare to ABT and SYK?
SciBase Holding AB's Construction In Progress of kr0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Medical Devices & Instruments company?
A good Construction In Progress depends on the Medical Devices & Instruments industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on SciBase Holding AB and its competitors. SciBase Holding AB's current Construction In Progress is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SciBase Holding AB stock overvalued right now?
Based on GuruFocus' analysis, SciBase Holding AB (OSTO:SCIB) is currently considered Significantly Overvalued. The stock's GF Value™ is kr21.74, compared to a current price of kr33.80 — trading 55.5% above its estimated fair value. The current Construction In Progress is kr0.00 Mil. SciBase Holding AB's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For SciBase Holding AB (OSTO:SCIB), the current Construction In Progress is kr0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SciBase Holding AB (OSTO:SCIB) Overvalued in 2026?

Based on GuruFocus' analysis, SciBase Holding AB stock appears to be overvalued. The current stock price of kr33.80 is trading 55.5% above its estimated GF Value™ of kr21.74. GuruFocus considers SciBase Holding AB to be Significantly Overvalued.

Key valuation signals for OSTO:SCIB:

  • Construction In Progress: kr0.00 Mil
  • GF Value™: kr21.74 vs. price of kr33.80 (55.5% above fair value)
  • GF Score™: 50/100 with 4 warning signs

No single metric tells the full story. See the OSTO:SCIB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SciBase Holding AB Business Description

Address Landsvagen 39, Sundbyberg, Stockholm, SWE, 172 63
SciBase Holding AB is a medical technology company specializing in early detection of skin cancer and prevention in dermatology. SciBase develops, manufactures, and commercializes Nevisense, a point-of-care technology platform that combines AI (artificial intelligence) and EIS technology to elevate diagnostic accuracy and support the prevention of skin diseases. The company's product portfolio consists of the Nevisense platform technology for multiple clinical applications and proprietary Nevisense electrodes. The products are based on measurements using electrical impedance spectroscopy (EIS), analysed using custom artificial intelligence (AI)-based algorithms. The company operates in two segments, which include skin cancer and skin barrier assessment.
50GF Score

Get the complete analysis for OSTO:SCIB

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr33.80
Price
kr21.74
GF Value